Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
FDA Office of Acquisition Grant Services
This contract includes 1 purchase order from Jul 28, 2025 to Jul 28, 2025
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| FDA Office of Acquisition Grant Services | WE Pharma, Inc. | Jul 28, 2025 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
FDA Office of Acquisition Grant Services
PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
Effective Date
Sep 16, 2025
Expires
Effective: Sep 16, 2025
FDA Office of Acquisition Grant Services
Expires:
PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
ActiveFDA Office of Acquisition Grant Services
TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.
Effective Date
Jul 2, 2024
Expires
FDA Office of Acquisition Grant Services
Expires:
TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.
ActiveFDA Office of Acquisition Grant Services
PHARMACEUTICAL DRUG PRODUCTS
Effective Date
May 14, 2025
Expires
Effective: May 14, 2025
FDA Office of Acquisition Grant Services
Expires:
PHARMACEUTICAL DRUG PRODUCTS
ActiveFDA Office of Acquisition Grant Services
EO14042 "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" BPA FOR THE FDA
Effective Date
Sep 26, 2022
Expires
Effective: Sep 26, 2022
FDA Office of Acquisition Grant Services
Expires:
EO14042 "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" BPA FOR THE FDA
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis